Table 1.

Information on the enrolled volunteers.

Sample Number	Age	Gender	Cancer Type	Treatment
N1	42	Male	-	-
N2	40	Male	-	-
N3	39	Male	-	-
N4	27	Male	-	-
P1	68	Female	Lung cancer (late stage)	None a
P2	71	Male	Lung cancer (late stage)	None a
P3	74	Female	Lung cancer (late stage)	None a
P4	51	Female	Lung cancer (late stage)	None a
P7	75	male	Hard palate	Nivolumab b
P9	54	female	Skin	Nivolumab b
P10	52	male	Hypopharynx	Pembrolizumab b

^a The blood samples were collected before clinical therapies. ^b The blood samples were collected after immunotherapies.